本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Neurosense Therapeutics Ltd

7.03
+0.13001.88%
盤後7.02-0.0100-0.14%19:50 EDT
成交量:4.23萬
成交額:28.60萬
市值:1,327.48萬
市盈率:-0.81
高:7.29
開:6.43
低:6.06
收:6.90
52周最高:26.64
52周最低:5.00
股本:188.83萬
流通股本:129.23萬
量比:1.45
換手率:3.27%
股息:- -
股息率:- -
每股收益(TTM):-8.7319
每股收益(LYR):-8.7319
淨資產收益率:-2174.98%
總資產收益率:-247.30%
市淨率:-8.51
市盈率(LYR):-0.81

資料載入中...

2023/08/14

SEC問詢函

Form CORRESP - Correspondence
2023/07/21

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/04/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/22

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/26

SEC問詢函

CORRESP [Cover] - Correspondence
2022/04/14

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/12/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/06

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/12/06

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/19

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/19

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/11/10

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers